Panorama France HealthTech 2026 's review: a mature, innovative and resilient sector facing a more demanding environment-- An ecosystem of nearly 2,800 companies, driven by innova ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

But in the last three years, the company has sought to leverage its footholds in China and the U.S. to become a multinational ...

Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

The Biotechnology Innovation Organization (BIO) has started the nationwide “​The Fight of Our Lives” campaign, creating a ...

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on ...

Kentucky-based Aristides Capital sold 28,467 shares of IBB in the third quarter. The shares were worth an estimated $3.60 million. The move marked a full exit from the position, which was previously ...

The situation involving Sam Chun Dang Pharm, which rose to the top of the KOSDAQ market capitalization at the end of last ...